Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis

ClinicalTrials.gov ID: NCT05050136

Public ClinicalTrials.gov record NCT05050136. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 6:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients With Primary Biliary Cholangitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this clinical research study is to learn more about the use of the study medicine, volixibat, for the treatment of pruritus (itching) associated with Primary Biliary Cholangitis (PBC), and to assess the possible impact on the disease progression of PBC.

Study identification

NCT ID
NCT05050136
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Mirum Pharmaceuticals, Inc.
Industry
Enrollment
333 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 22, 2021 (Actual)
Primary completion
Jan 2027 (Estimated)
Completion
Dec 2028 (Estimated)
Last update posted
Aug 25, 2026

2021 – 2028

United States locations

U.S. sites
44
U.S. states
22
U.S. cities
41
Facility City State ZIP Site status
Southern California Research Center Coronado California 92218 —
Cedars Sinai Medical Center Los Angeles California 90048 —
University of California Los Angeles Los Angeles California 90095 —
UC Davis Sacramento California 95817 —
University of Colorado Aurora Colorado 80045 —
Yale University Digestive Diseases New Haven Connecticut 06510 —
Covenant Metabolic Specialists Fort Myers Florida 33912 —
UF Hepatology Research at CTRB Gainesville Florida 32610 —
UF Health Gastroenterology- Emerson Jacksonville Florida 32209 —
IHS Health Kissimmee Florida 34741 —
Schiff Center for Liver Diseases Miami Florida 33136 —
Advanced Research Institute, Inc New Port Richey Florida 34653 —
Covenant Research and Clinics, LLC Sarasota Florida 34240 —
Tampa General Hospital Tampa Florida 33606 —
Cleveland Clinic Florida Weston Florida 33331 —
Southeast Clinical Research Center Dalton Georgia 30720 —
Northwestern University Chicago Illinois 60611 —
Loyola University Health System - Loyola Outpatient Center Maywood Illinois 60153 —
University of Iowa Hospitals & Clinics Iowa City Iowa 52242 —
Ochsner Clinic Foundation-Baton Rouge Baton Rouge Louisiana 70836 —
LSU Health Science Center Shreveport Shreveport Louisiana 71103 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Beth Israel Deaconess Boston Massachusetts 02215 —
Mayo Clinic Rochester Minnesota 55905 —
Jackson Liver and GI Specialists Jackson Mississippi 39216 —
CHI Health Clinic (Alegent Creighton Clinic)- Gastroenterology-Bergan Omaha Nebraska 68124 —
Virtua Center for Liver Disease-Camden Camden New Jersey 08103 —
Montefiore Medical Center The Bronx New York 10467 —
Science 37, Inc (Remote-homebased Telemedicine) Morrisville North Carolina 27560 —
Cleveland Clinic - Main Campus Cleveland Ohio 44195 —
Einstein Healthcare Network - Einstein Medical Center Philadelphia Pennsylvania 19141 —
Methodist Le Bonheur Healthcare Memphis Tennessee 38104 —
Galen Medical Group, P.C Tennessee City Tennessee 37343 —
Amel Med LLC Austin Texas 78750 —
The Liver Institute at Methodist Dallas Medical Center Dallas Texas 75203 —
Soma Clinical Trials Denison Texas 75020 —
Baylor College of Medicine Houston Texas 77030 —
Liver Associates of Texas Houston Texas 77030 —
Impact Research Waco Texas 76710 —
University of Utah Health Care Salt Lake City Utah 84132 —
MedStar Health Research Institute Fairfax Virginia 22031 —
Bon Secours Liver Institute of Hampton Roads Mary Immaculate Hospital Newport News Virginia 23602 —
Bon Secours Richmond Community Hospital LLC d/b/a Bon Secours Liver Institute of Richmond Richmond Virginia 23226 —
Liver Institute Northwest Seattle Washington 98105 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 86 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05050136, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 25, 2026 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05050136 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →